Martina Mazzocchi
Cork, M, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Maternal immune activation and antibiotics affect offspring neurodevelopment, behaviour, and microbiome.
Journal: Brain, behavior, & immunity - health
Published: January 21, 2025
The class-IIa HDAC inhibitor TMP269 promotes BMP-Smad signalling and is neuroprotective in in vitro and in vivo 6-hydroxydopamine models of Parkinson's disease.
Journal: Neuropharmacology
Published: September 13, 2024
Bioinformatics and Immunohistochemical Analyses Support Preserved Expression of Glial Cell Line-Derived Neurotrophic Factor Receptor RET in Parkinson's.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: January 31, 2023
A combined proteomics and bioinformatics analysis of ZNHIT1-interacting proteins reveals a significant enrichment in proteins associated with mitochondrial function.
Journal: Journal of chemical neuroanatomy
Published: December 14, 2022
A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primates.
Journal: PloS one
Published: December 13, 2022
Gene Co-expression Analysis of the Human Substantia Nigra Identifies ZNHIT1 as an SNCA Co-expressed Gene that Protects Against α-Synuclein-Induced Impairments in Neurite Growth and Mitochondrial Dysfunction in SH-SY5Y Cells.
Journal: Molecular neurobiology
Published: November 23, 2021
Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease.
Journal: Brain, behavior, and immunity
Published: November 11, 2021
LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's disease.
Journal: Molecular and cellular neurosciences
Published: March 04, 2021
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia.
Journal: British journal of pharmacology
Published: February 24, 2021
The class II histone deacetylases as therapeutic targets for Parkinson's disease.
Journal: Neuronal signaling
Published: January 22, 2020
Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling.
Journal: Frontiers in cell and developmental biology
Published: June 14, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026